CeraVe, one of the most widely used dermatologist-recommended skincare brands in the United States, is currently facing six federal class action lawsuits. The cases target two of its acne treatment products that contain benzoyl peroxide, a common active ingredient used to treat breakouts. The brand is owned by L’Oréal, and while no final judgment has been reached, the allegations have raised serious questions about chemical stability in everyday skincare products.
The core of the lawsuits is not that CeraVe added a harmful substance on purpose. Instead, the argument is that the acne ingredient in these products may chemically change under certain conditions and form benzene — a substance classified globally as a confirmed human carcinogen. The legal focus is on whether consumers were clearly warned about this possibility before using the products.
How the Allegations Started and Who Is Behind Them
The concerns first came into public and regulatory attention after independent testing conducted by Valisure, a private laboratory known for analyzing pharmaceutical and consumer products. Their findings suggested that benzoyl peroxide, the active ingredient in many acne treatments, may break down and form benzene when exposed to heat or extended storage conditions.
This triggered a wave of legal filings beginning in 2024, with individual plaintiffs bringing cases against L’Oréal USA in different U.S. states. These lawsuits were later consolidated into federal court proceedings, where six class action cases are now active.At this stage, the cases are still ongoing. There has been no recall of CeraVe acne products related to these claims, and no court has issued a final ruling against the company.
Benzoyl Peroxide and the Chemical Concern at the Center
Benzoyl peroxide is one of the most widely used ingredients in acne treatment globally. It works by releasing oxygen inside pores, which helps kill acne-causing bacteria and reduce breakouts. It is FDA-approved and found in a large number of over-the-counter skincare products.
The concern raised in this case is about what happens after manufacturing. Studies and lab tests suggest that benzoyl peroxide is not fully stable and may break down under certain temperatures. One of the substances it may form during this breakdown is benzene.
Benzene is not a minor chemical concern. It is classified as a Group 1 carcinogen, meaning it has strong scientific evidence linking it to cancers such as leukemia and lymphoma. Because of this classification, even very small exposures are closely regulated.However, regulators argue that under normal usage and storage conditions, exposure levels from skincare products remain extremely low. This difference between lab conditions and real-world use is one of the key scientific disagreements in the case.
Regulatory Findings, Industry Response, and Legal Arguments
Following Valisure’s findings, the U.S. Food and Drug Administration conducted its own review of acne products containing benzoyl peroxide. The majority of tested products showed either no detectable benzene or levels within acceptable safety limits under standard storage conditions. A small number of products were flagged and voluntarily recalled by manufacturers, but CeraVe’s acne products were not part of those recalls.
The FDA has also stated that even with long-term daily use, the risk of cancer from benzene exposure in these products is considered very low under normal conditions.
Despite this, the lawsuits argue something different. The central claim is not simply about whether benzene exists, but whether companies had a responsibility to warn consumers that an ingredient in their product could potentially degrade into a carcinogen under foreseeable conditions like heat or long-term storage.This creates a legal grey area between product safety as manufactured versus product behavior over time — and that is now at the center of the litigation.
Why This Case Matters Beyond CeraVe
Although CeraVe is the brand currently in focus, benzoyl peroxide is not unique to its products. It is used across hundreds of acne treatments from multiple skincare companies worldwide. That means the outcome of these lawsuits could influence how an entire category of skincare products is regulated and labeled.
If courts decide that manufacturers must disclose potential chemical changes under realistic usage conditions, it could reshape labeling standards across the industry. It would also raise broader questions about how skincare safety is communicated to consumers — not just in terms of ingredients, but in terms of how those ingredients behave over time.
For now, the case remains unresolved. But it has already shifted attention toward a part of skincare that is often overlooked: not just what you apply to your skin, but what that product can become after it leaves the shelf.
Sources: About Lawsuits, Animal Base, Yahoo
For more such news, head over to our Instagram.
